Navigation Links
Lab tests key to identifying, treating infectious diseases
Date:7/10/2013

[EMBARGOED FOR July 11, 2013, ARLINGTON, Va.] A new guide developed by the Infectious Diseases Society of America (IDSA) and the American Society for Microbiology (ASM) will help physicians appropriately and accurately use laboratory tests for the diagnosis of infectious diseases. Laboratory test results drive approximately two-thirds of physicians' medical decisions.

Published today in the journal Clinical Infectious Diseases, the recommendations provide guidance regarding which lab tests are valuable and should be used in specific contexts; which add little or no value; and how to appropriately collect and manage specimens.

Laboratory diagnoses directly affect patient care and outcomes, as well as hospital infection control, patients' length of stay in the hospital, costs and laboratory efficiency.

"Getting the right diagnosis is contingent upon laboratory results that are accurate and clinically relevant," says Ellen Jo Baron, PhD, who worked with J. Michael Miller, PhD, to shepherd the guide to completion after its inception by Gary Doern, PhD. "Physicians, their staff and microbiologists must communicate and work together to ensure the best outcome for patients, and this guide aims to help facilitate this collaboration."

Divided into sections on anatomic systems (including infections of the bloodstream, cardiovascular system, central nervous system, eyes, soft tissue of the head and neck, upper and lower respiratory system, gastrointestinal tract, abdomen, bone and joints, urinary tract, genitals and skin and soft tissues) and etiologic agent groups (tickborne infections, viral syndromes, blood and tissue and parasite infections), the guide helps physicians decide what tests to request when they suspect specific agents are causing disease. It also provides targeted recommendations and precautions regarding selecting and collecting specimens, detailing what is required for various cultures and tests, as well as the appropriate collection device, temperature and ideal transport time.

The guide suggests 10 tenets of specimen management that everyone involved from physician to nurse to laboratory scientist should follow for good patient care. These include:

  1. Specimens of poor quality must be rejected or results could be compromised.
  2. Physicians should not demand a report of "everything that grows" as this could result in an inaccurate diagnosis.
  3. Avoiding contamination of specimens is key, and careful collection is crucial.
  4. The laboratory requires a specimen, not a swab of a specimen, which may not hold enough infected material to ensure an accurate diagnosis and may be easily contaminated.
  5. The laboratory must follow its procedure manual or face legal challenges.
  6. A specimen should be collected prior to administration of antibiotics, presence of which could lead to misleading results.
  7. Susceptibility testing should be performed on clinically significant isolates, not all microorganisms in the culture.
  8. Lab results should be accurate, significant and clinically relevant.
  9. The laboratory not the medical staff should be allowed to set technical policy. Good communication and mutual respect will lead to collaborative policies.
  10. Specimens must be labeled accurately and completely (for example: dog bite wound, right forefinger).

Guidance provided in the document is not intended to take the place of a doctor's judgment, but rather to support the decision-making process, which must be individualized according to each patient's circumstances.


'/>"/>

Contact: Jerica Pitts
jpitts@pcipr.com
312-558-1770
Infectious Diseases Society of America
Source:Eurekalert

Related medicine news :

1. Physician Groups Call for Fewer Medical Tests
2. Range of diagnostic spinal fluid tests needed to differentiate concurrent brain diseases
3. URMC clinical trial tests new regimen for hypertension
4. Smell Tests Dont Predict Alzheimers, Study Finds
5. Are Post-Angioplasty Stress Tests Unnecessary?
6. OSHAs Safety Tests Protect Workers at Little Cost: Study
7. Gene Tests May Not Drive Patients to More Medical Care
8. Better tests for sleeping sickness
9. U.S. Advisers Say No to Routine PSA Tests for Prostate Cancer
10. Breast cancer clinical trial tests combo of heat shock protein inhibitor and hormonal therapy
11. Super-sensitive tests could detect diseases earlier
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/28/2017)... ... 28, 2017 , ... Resoundant, Inc., the developer of ... Healthineers annual customer education symposium, a world-class learning conference that offers educational content ... - 31, 2017 at the Atlanta Marriott Marquis in Atlanta, Georgia. , Innovations ...
(Date:3/28/2017)... ... March 29, 2017 , ... The Thyroid ... Isabella Wentz, Pharm.D., FASCP. The program was recently launched on March 1, and ... regarding thyroid function. , Dr. Izabella Wentz is a licensed pharmacist and ...
(Date:3/28/2017)... , ... March 28, 2017 , ... ... share of all holidays (IBT World Travel Trends Report). As travelers visit both ... a range in temperatures, and prolonged sun exposure. In response, the outdoor industry ...
(Date:3/28/2017)... ... March 28, 2017 , ... ... the science and clinical practice of radiosurgery, announced today the publication of ... observational registry established to standardize data collection from patients treated with stereotactic ...
(Date:3/28/2017)... (PRWEB) , ... March 28, 2017 , ... Alert Sentry ... of MPERS (Mobile Personal Emergency Response Systems), the iSAFE and the iSAFE Plus. These ... market. The first of their kind, the iSAFE and iSAFE Plus offer direct GPS ...
Breaking Medicine News(10 mins):
(Date:3/28/2017)... March 28, 2017  Orexigen Therapeutics, Inc. (Nasdaq: ... for the fourth quarter and year ended December 31, ... of transformational progress for Orexigen, beginning with the re-acquisition ... Commencing early March, the team at Orexigen demonstrated remarkable ... which reshaped and strengthened our Company while rewarding us ...
(Date:3/28/2017)... BOSTON , March 28, 2017  Market ... today announced a partnership with premium news content ... pharmaceutical companies to extract key insights from Dow ... mining technology. The Linguamatics I2E platform ... 20 global pharmaceutical companies. The Linguamatics-Dow Jones partnership ...
(Date:3/28/2017)... 28, 2017  AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), ... and commercialization of innovative therapies for the treatment ... Medicines Agency (EMA) has notified the company that ... Authorisation Application (MAA) has passed validation, and that ... The MAA for ARX-04 (known as DSUVIA™ in ...
Breaking Medicine Technology: